← SynDRA
PRT062070
SynDRA canonical compound SYN1970634 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
| Primary target(s) | SYK |
| Mechanism of action | JAK inhibitor | SYK inhibitor |
All known targets
Mechanisms of action (all sources)
- JAK inhibitor
- SYK INHIBITOR
Cross-references
Synonyms
- Cerdulatinib
- Cerdulatinib (PRT062070)
- Cerdulatinib [INN]
- 4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide
- PRT 062070
- D1LXQ45S1O
- CHEMBL4116008
- RVT-502
- PRT-2070
- 4-(Cyclopropylamino)-2-((4-(4-(ethanesulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide
- 5-Pyrimidinecarboxamide, 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)-1-piperazinyl)phenyl)amino)-
- PRT2070
- UNII-D1LXQ45S1O
- 4-(cyclopropylamino)-2-({4-[4-(ethanesulfonyl)piperazin-1-yl]phenyl}amino)pyrimidine-5-carboxamide
- Cerdulatinib (PRT2070)
- CERDULATINIB [WHO-DD]
- SCHEMBL736734
- GTPL8957
- DTXSID001115521
- BCP10681
- EX-A2143
- YXB30079
- BDBM50468574
- NSC800071
- NSC825827
- s3566
- AKOS026750510
- ZINC114483165
- CS-3329
- DB15499
- NSC-800071
- NSC-825827
- SB16931
- Cerdulatinib; PRT062070; PRT2070
- NCGC00386415-04
- 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide
- AC-30243
- AS-56368
- DA-34986
Look up PRT062070 in the interactive SynDRA portal →